Director/PDMR Shareholding

RNS Number : 4191L

ReNeuron Group plc

12 August 2013

 

DTR3

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

All relevant boxes should be completed in block capital letters.

1.	Name of the issuer ReNeuron Group plc	2.	State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.2R; or (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) in accordance with section 793 of the Companies Act 2006 (i)
3.	Name of person discharging managerial responsibilities/director Dr. John Sinden	4.	State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person Director named in 3.
5.	Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest 1 Interest of person named in 3	6.	Description of shares (including class), debentures or derivatives or financial instruments relating to shares Ordinary Shares
7.	Name of registered shareholders(s) and, if more than one, the number of shares held by each of them Person named in 3	8.	State the nature of the transaction Placing of Ordinary Shares
9.	Number of shares, debentures or financial instruments relating to shares acquired Acquisition of 600,000 Ordinary Shares	10.	Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.034%
11.	Number of shares, debentures or financial instruments relating to  shares disposed	12.	Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
13.	Price per share or value of transaction 2.5 pence per Ordinary Share	14.	Date and place of transaction 9 August 2013
15.	Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) Dr John Sinden is interested in a total of 2,211,902 Ordinary Shares in the Company representing approximately 0.124% of issued Ordinary Shares.	16.	Date issuer informed of transaction 9 August 2013

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17.	Date of grant	18.	Period during which or date on which it can be exercised
19.	Total amount paid (if any) for grant of the option	20.	Description of shares or debentures involved (class and number)
21.	Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise	22.	Total number of shares or debentures over which options held following notification
23.	Any additional information See table of options held by Dr. John Sinden below: Number of options Exercise Price End of Exercise Period 806,370 5.06p July 2014 965,131 5.06p July 2014 1,975,621 12.65p August 2015 493,339 5.07p August 2016 493,339 7.6p August 2016 860,328 12.2p August 2017 860,328 21.79p August 2017 1,564,642 1.0p August 2020 1,713,637 1.0p August 2019 1,918,782 1.0p August 2020 2,336,389 1.0p August 2021 2,450,758 1.0p September 2022 16,438,664	24.	Name of contact and telephone number for queries Pat Huggins, Reneuron Group Plc [phone]

Name of authorised official of issuer responsible for making notification: Patrick Huggins, Head of Finance and Company Secretary Date of notification: 9 August 2013

 

END

 

 

RDSLLFSETLIAIIV